Description
Dalmaxin (Thiotriazolin) Suppositories 0.2 g. №10
Ingredients
Active ingredient: Thiotriazolin 0.2 g per suppository.
Mechanism of Action
Thiotriazolin, the active ingredient in Dalmaxin suppositories, acts as an antioxidant and anti-inflammatory agent. It protects the vascular endothelium, enhances microcirculation, and reduces oxidative stress and inflammation in vascular diseases.
Pharmacological Properties
Dalmaxin suppositories deliver thiotriazolin directly to the affected area, ensuring optimal absorption and effectiveness in treating vascular conditions.
Indications for Use
Dalmaxin suppositories are indicated for the treatment of vascular diseases, including peripheral arterial disease and venous insufficiency.
Contraindications
Do not use Dalmaxin suppositories in case of hypersensitivity to thiotriazolin or any other component of the product.
Side Effects
No common side effects have been reported with the proper use of Dalmaxin suppositories. However, individual reactions may vary.
Usage Instructions
Dosage: The usual dosage is 1 suppository inserted into the rectum 1-2 times a day. Before and after use, wash hands thoroughly. Lie on your side and gently insert the suppository into the rectum. Wash hands again after application.
Benefits Compared to Analogues
Dalmaxin suppositories offer targeted delivery of thiotriazolin, providing direct benefits to vascular health with minimal systemic effects compared to oral medications.
Suitable Patient Groups
Dalmaxin suppositories are suitable for adult patients with vascular diseases. Consult a healthcare professional for appropriate use in specific patient populations, such as children and the elderly.
Storage and Shelf Life
Store Dalmaxin suppositories in a cool, dry place away from direct sunlight. Check the packaging for the expiration date and do not use expired products.
Packaging Description
Dalmaxin suppositories are available in packs of 10 suppositories, each containing 0.2 g of thiotriazolin.
Clinical Evidence and Proven Effectiveness
Thiotriazolin has shown promising results in clinical trials for improving symptoms of peripheral arterial disease and venous insufficiency. Patients experienced significant relief in pain, swelling, and overall vascular health with the use of Dalmaxin suppositories.
